High Risk Myelodysplastic syndromes (HR-MDS) –Takeda, Gilead, Onconova Therapeutics & MEI Pharma
Myelodysplastic syndromes (MDS) is a rare form of bone marrow-related cancer caused by mutation of one or more genes that control development of blood cells. This cancer most commonly affects older patients, with the median […]